Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of Varying Doses of Prucalopride on Improving Gut Function Recovery After Elective Colorectal Surgery
Sponsor: Future University in Egypt
Summary
Postoperative ileus (POI) is a common complication after abdominal surgery, causing symptoms like nausea, vomiting, abdominal distension, and delayed passage of flatus and stool. Management remains challenging, with limited pharmacological options available. Prucalopride, a selective serotonin 5-HT4 receptor agonist, has shown promise in accelerating gastrointestinal recovery after surgery. However, the optimal timing and dosing for preventing POI remains unclear. Higher doses may provide more potent prokinetic effects in the postoperative setting. his study investigates if higher doses of prucalopride (4 mg) improve bowel function return and hospital stay in elective colorectal surgery patients compared to standard doses and placebo.
Official title: The Effect of Different Doses of Prucalopride on Improving Gut Function Recovery Following Elective Colorectal Surgery: a Randomized, Double-blind Study
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2025-03-02
Completion Date
2025-05
Last Updated
2025-03-19
Healthy Volunteers
No
Conditions
Interventions
Prucalopride 2mg
Prucalopride 2mg taken preoperatively
Prucalopride 4mg
Prucalopride 4mg taken preoperatively
Standard Care
Standard Supportive care
Locations (1)
Matareya Hospital
Cairo, Egypt